病例报告:褪黑素治疗saethree - chotzen综合征的原发性刺痛性头痛

Q3 Medicine Cephalalgia Reports Pub Date : 2023-01-01 DOI:10.1177/25158163231206999
Florian Frank, Vera Filippi, Katharina Kaltseis, Gregor Broessner
{"title":"病例报告:褪黑素治疗saethree - chotzen综合征的原发性刺痛性头痛","authors":"Florian Frank, Vera Filippi, Katharina Kaltseis, Gregor Broessner","doi":"10.1177/25158163231206999","DOIUrl":null,"url":null,"abstract":"Background: Primary stabbing headache (PSH) is a rare primary headache presenting with short, stabbing pain sensations of unknown etiology. Owed to the rare prevalence of the disease, only limited data exists on possible treatment options. The most cumulative expertise exists for indomethacin as a potential treatment in PSH. However, known side effects and long-term tolerability issues have urged the FDA to restrict the use of indomethacin as long-term medication. In about 35% of the cases indomethacin does not provide sufficient relieve, demanding for efficacious and well tolerable alternatives. Case: Herewith we report a case of a young female adult presenting with PSH treated with melatonin resulting in an outstanding and long-lasting response. The patient has a rare underlying genetic disorder leading to facial dysmorphia, which according to the scarce literature, is not associated with PSH so far, but requires extensive exclusion of secondary causes of headaches. Conclusion: Given the exceptional tolerability of melatonin with low concern even on a long-term use, we discuss an indomethacin trial in PSH might be a diagnostic approach rather than a therapeutic one in the future.","PeriodicalId":9702,"journal":{"name":"Cephalalgia Reports","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Case report: Primary stabbing headache treated with melatonin in Saethre-Chotzen syndrome\",\"authors\":\"Florian Frank, Vera Filippi, Katharina Kaltseis, Gregor Broessner\",\"doi\":\"10.1177/25158163231206999\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Primary stabbing headache (PSH) is a rare primary headache presenting with short, stabbing pain sensations of unknown etiology. Owed to the rare prevalence of the disease, only limited data exists on possible treatment options. The most cumulative expertise exists for indomethacin as a potential treatment in PSH. However, known side effects and long-term tolerability issues have urged the FDA to restrict the use of indomethacin as long-term medication. In about 35% of the cases indomethacin does not provide sufficient relieve, demanding for efficacious and well tolerable alternatives. Case: Herewith we report a case of a young female adult presenting with PSH treated with melatonin resulting in an outstanding and long-lasting response. The patient has a rare underlying genetic disorder leading to facial dysmorphia, which according to the scarce literature, is not associated with PSH so far, but requires extensive exclusion of secondary causes of headaches. Conclusion: Given the exceptional tolerability of melatonin with low concern even on a long-term use, we discuss an indomethacin trial in PSH might be a diagnostic approach rather than a therapeutic one in the future.\",\"PeriodicalId\":9702,\"journal\":{\"name\":\"Cephalalgia Reports\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cephalalgia Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/25158163231206999\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cephalalgia Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25158163231206999","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

背景:原发性刺痛性头痛(PSH)是一种罕见的原发性头痛,表现为短暂的刺痛感,病因不明。由于该疾病罕见流行,关于可能的治疗方案的数据有限。对于吲哚美辛作为PSH的潜在治疗方法,积累的专业知识最多。然而,已知的副作用和长期耐受性问题促使FDA限制使用吲哚美辛作为长期药物。在大约35%的病例中,吲哚美辛不能提供足够的缓解,需要有效且耐受性良好的替代品。病例:在此,我们报告一例年轻的女性成人呈现PSH与褪黑激素治疗导致一个突出的和持久的反应。患者有一种罕见的导致面部畸形的潜在遗传疾病,根据稀缺的文献,到目前为止与PSH无关,但需要广泛排除头痛的继发原因。结论:考虑到褪黑素的特殊耐受性,即使在长期使用中也不受关注,我们讨论了在PSH中进行吲哚美辛试验可能是一种诊断方法而不是治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Case report: Primary stabbing headache treated with melatonin in Saethre-Chotzen syndrome
Background: Primary stabbing headache (PSH) is a rare primary headache presenting with short, stabbing pain sensations of unknown etiology. Owed to the rare prevalence of the disease, only limited data exists on possible treatment options. The most cumulative expertise exists for indomethacin as a potential treatment in PSH. However, known side effects and long-term tolerability issues have urged the FDA to restrict the use of indomethacin as long-term medication. In about 35% of the cases indomethacin does not provide sufficient relieve, demanding for efficacious and well tolerable alternatives. Case: Herewith we report a case of a young female adult presenting with PSH treated with melatonin resulting in an outstanding and long-lasting response. The patient has a rare underlying genetic disorder leading to facial dysmorphia, which according to the scarce literature, is not associated with PSH so far, but requires extensive exclusion of secondary causes of headaches. Conclusion: Given the exceptional tolerability of melatonin with low concern even on a long-term use, we discuss an indomethacin trial in PSH might be a diagnostic approach rather than a therapeutic one in the future.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cephalalgia Reports
Cephalalgia Reports Medicine-Neurology (clinical)
CiteScore
2.50
自引率
0.00%
发文量
17
审稿时长
9 weeks
期刊最新文献
Protocol of a cross-sectional, multicentre and multidisciplinary study describing phenotype and burden of a midfacial segment pain Paranoid psychosis after a single parenteral dose of indomethacin administered for headache diagnosis: A case and review of the literature Extended regular use of kinetic oscillation stimulation (KOS) in refractory chronic migraine: case report of a first, single-subject experience Corrigendum to “Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies” A century of bruxism research in top-ranking medical journals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1